170 related articles for article (PubMed ID: 2225437)
1. Late results with Carpentier-Edwards porcine bioprosthesis.
Akins CW; Carroll DL; Buckley MJ; Daggett WM; Hilgenberg AD; Austen WG
Circulation; 1990 Nov; 82(5 Suppl):IV65-74. PubMed ID: 2225437
[TBL] [Abstract][Full Text] [Related]
2. Twenty-year clinical experience with porcine bioprostheses.
Fann JI; Miller DC; Moore KA; Mitchell RS; Oyer PE; Stinson EB; Robbins RC; Reitz BA; Shumway NE
Ann Thorac Surg; 1996 Nov; 62(5):1301-11; discussion 1311-2. PubMed ID: 8893561
[TBL] [Abstract][Full Text] [Related]
3. Aortic and mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 10-year results.
Murakami T; Eishi K; Nakano S; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kito Y; Kawashima Y
J Heart Valve Dis; 1996 Jan; 5(1):45-9. PubMed ID: 8834725
[TBL] [Abstract][Full Text] [Related]
4. Carpentier-Edwards porcine bioprostheses: clinical performance assessed by actual analysis.
Jamieson WR; Miyagishima RT; Burr LH; Lichtenstein SV; Fradet GJ; Janusz MT
J Heart Valve Dis; 2000 Jul; 9(4):530-5. PubMed ID: 10947046
[TBL] [Abstract][Full Text] [Related]
5. Fifteen years follow up with the St. Jude Medical Biocor porcine bioprosthesis.
Mykén P; Bech-Hanssen O; Phipps B; Caidahl K
J Heart Valve Dis; 2000 May; 9(3):415-22. PubMed ID: 10888100
[TBL] [Abstract][Full Text] [Related]
6. The Carpentier-Edwards standard porcine bioprosthesis. A first-generation tissue valve with excellent long-term clinical performance.
Jamieson WR; Allen P; Miyagishima RT; Gerein AN; Munro AI; Burr LH; Tyers GF
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):543-61. PubMed ID: 2308373
[TBL] [Abstract][Full Text] [Related]
7. Eighteen-year follow up after Hancock II bioprosthesis insertion.
Legarra JJ; Llorens R; Catalan M; Segura I; Trenor AM; de Buruaga JS; Rabago G; Sarralde A
J Heart Valve Dis; 1999 Jan; 8(1):16-24. PubMed ID: 10096477
[TBL] [Abstract][Full Text] [Related]
8. Randomized, prospective assessment of bioprosthetic valve durability. Hancock versus Carpentier-Edwards valves.
Sarris GE; Robbins RC; Miller DC; Mitchell RS; Moore KA; Stinson EB; Oyer PE; Reitz BA; Shumway NE
Circulation; 1993 Nov; 88(5 Pt 2):II55-64. PubMed ID: 8222197
[TBL] [Abstract][Full Text] [Related]
9. Porcine versus pericardial bioprostheses: eleven-year follow up of a prospective randomized trial.
Chaudhry MA; Raco L; Muriithi EW; Bernacca GM; Tolland MM; Wheatley DJ
J Heart Valve Dis; 2000 May; 9(3):429-37; discussion 437-8. PubMed ID: 10888102
[TBL] [Abstract][Full Text] [Related]
10. Five-year evaluation of the Carpentier-Edwards porcine bioprosthesis.
Jamieson WR; Pelletier LC; Janusz MT; Chaitman BR; Tyers FO; Miyagishima RT
J Thorac Cardiovasc Surg; 1984 Sep; 88(3):324-33. PubMed ID: 6381888
[TBL] [Abstract][Full Text] [Related]
11. [Influence of the valve position on the complications related to pericardial Carpentier-Edwards valve after 8 years].
Aupart M; Dreyfus X; Meurisse Y; May MA; Sirinelli A; Marchand M
Arch Mal Coeur Vaiss; 1995 Jul; 88(7):967-71. PubMed ID: 7487327
[TBL] [Abstract][Full Text] [Related]
12. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
Mykén PS
J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
[TBL] [Abstract][Full Text] [Related]
13. The Medtronic Intact porcine bioprosthesis: clinical performance to eight years.
Munro AI; Jamieson WR; Tyers GF; Burr LH
J Heart Valve Dis; 1994 Nov; 3(6):634-40. PubMed ID: 8000606
[TBL] [Abstract][Full Text] [Related]
14. Medtronic mosaic porcine bioprosthesis: investigational center experience to six years.
Jamieson WR; Fradet GJ; MacNab JS; Burr LH; Stanford EA; Janusz MT; Abel JG; Germann E; Cheung A
J Heart Valve Dis; 2005 Jan; 14(1):54-63. PubMed ID: 15700437
[TBL] [Abstract][Full Text] [Related]
15. The Mitroflow pericardial bioprosthesis. Comparison of early clinical performance in aortic and mitral positions.
Jamieson WR; Pelletier LC; Gerein AN; Pomar J
Can J Surg; 1992 Apr; 35(2):159-64. PubMed ID: 1562925
[TBL] [Abstract][Full Text] [Related]
16. The Carpentier-Edwards supraannular porcine bioprosthesis. A new generation tissue valve with excellent intermediate clinical performance.
Jamieson WR; Munro AI; Miyagishima RT; Burr LH; Gerein AN; Janusz MT; Tyers GF; Allen P
J Thorac Cardiovasc Surg; 1988 Oct; 96(4):652-66. PubMed ID: 3172812
[TBL] [Abstract][Full Text] [Related]
17. Mechanical versus bioprosthetic valve replacement in middle-aged patients.
Kulik A; Bédard P; Lam BK; Rubens FD; Hendry PJ; Masters RG; Mesana TG; Ruel M
Eur J Cardiothorac Surg; 2006 Sep; 30(3):485-91. PubMed ID: 16857373
[TBL] [Abstract][Full Text] [Related]
18. Durability of porcine valves at fifteen years in a representative North American patient population.
Burdon TA; Miller DC; Oyer PE; Mitchell RS; Stinson EB; Starnes VA; Shumway NE
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):238-51; discussion 251-2. PubMed ID: 1735989
[TBL] [Abstract][Full Text] [Related]
19. The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
Emery RW; Krogh CC; Arom KV; Emery AM; Benyo-Albrecht K; Joyce LD; Nicoloff DM
Ann Thorac Surg; 2005 Mar; 79(3):776-82; discussion 782-3. PubMed ID: 15734375
[TBL] [Abstract][Full Text] [Related]
20. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years.
Jamieson WR; Munro AI; Miyagishima RT; Allen P; Burr LH; Tyers GF
Ann Thorac Surg; 1995 Oct; 60(4):999-1006; discussion 1007. PubMed ID: 7575007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
